Prognostic factors in patients with hepatocellular carcinoma submitted to chemoembolization

Oncology Reports

Volumn 4, Issue 5, 1997, Pages 1025-1028

  Colleoni, Marco ^a,c   Liessi, Guido ^a   Mastrapasqua, Giorgio ^a   Boni, Luca ^b   Nelli, Patrizia ^a   Vicario, Giovanni ^a   Sgarbossa, Gigliola ^a   Pancheri, Francesca ^a   Manente, Paolo ^a  

^a City Hospital   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Intra arterial chemotherapy

Indexed keywords

CARBOPLATIN; EPIRUBICIN; ETHIODIZED OIL; FLUOROURACIL; FOLINIC ACID; GELATIN SPONGE; MITOXANTRONE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030741197     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.5.1025     Document Type: Article

References (33)

1. Ellis LM, Demers ML and Roh MS: Current strategies for the treatment of hepatocellular carcinoma. Curr Opin Oncol 4: 741-751, 1992.
2. Colleoni M, Gaion F, Liessi G, Mastropasqua G, Nelli P and Manente P: Medical treatment of hepatocellular carcinoma: any progress? Tumori 80: 315-326, 1994.
3. Nerenstone SR, Ihde DC and Friedman MA: Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treatment Rev 15: 1-31, 1988.
4. Takayasu K, Shima Y and Muramatsu Y: Hepatocellular carcinoma: treatment with intra-arterial iodized oil with and without a chemotherapeutic agent. Radiology 62: 345-351, 1991.
5. Johnson PJ, Kaayci C and Dobbs N: Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol. J Hepatol 13: 120-127, 1991.
6. Patt YZ, Chuang VP and Wallace S: Hepatic arterial chemotherapy and conclusion for palliation of primary hepatocellular and unknown primary neoplasm in the liver. Cancer 51: 1359-1363, 1983.
7. Patt YZ, Charnsangavej C and Boddie A: Treatment of hepatocellular carcinoma with hepatic arterial floxuridine, doxorubicin, and mitomycin C (Fudram) with or without hepatic arterial embolization: factors associated with longer survival. Reg Cancer Treat 2: 98-104, 1989.
8. Kalayci C, Johnson PJ and Raby N: Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin. J Hepatol 11: 349-353, 1990.
9. Kanematsu T, Furuta T, Takenata K, Inokuchi K and Tamura J: A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 10: 89-102, 1989.
10. Kasugai H, Kojima J and Tatsuta M: Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 97: 965-971, 1989.
11. Graupe d'etude et de Traitement du Carcinome Hepatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332: 1256-1261, 1995.
12. Colleoni M, Gaion F, Liessi G, Mastrapasqua G, Nelli P and Manente P: Arterial chemoembolization with epirubicin in unresectable hepatocellular carcinoma in cirrhosis. Oncol Rep 1: 1171-1175, 1994.
13. Pelletier G, Roche A and Ink O: A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 77: 181-184, 1990.
14. Sasaki Y, Imaoka S, Kasugai M, Fusita M, Kawamoto S and Ishiguro S: A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin and gelatinum sponge. Cancer 60: 1194-1203, 1987.
15. Stuart K, Stokes K, Jenkins R, Trey C and Clouse M: Treatment of HCC using doxorubicin/lipiodol/gelfoam. Cancer 72: 320-329, 1993.
16. Vennok AP, Stagg RJ and Lewis BJ: Chemoembolization for hepatocellular carcinoma. J Clin Oncol 8: 1108-1114, 1990.
17. Audisio RA, Doci R and Mazzaferro V: Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis. Cancer 66: 228-236, 1990.
18. Beppu T, Ohara C, Yamaguchu Y, Schihara T, Yamanaka T and Katafuchi S: A new approach to chemoembolization for unresectable HCC using aclarubicin microspheres in combination with cisplatin suspended iniodized oil. Cancer 68: 2555-2560, 1991.
19. Levin B and Amos C: Therapy of unresectable hepatocellular carcinoma. N Engl J Med 332: 1294-1296, 1995.
20. Yamashita T, Takahashi M and Koga Y: Prognostic factors in the treatment of HCC with TAE and arterial infusion. Cancer 67: 385-391, 1991.
21. Yamanaka N, Okamoto E and Toyosaka A: Prognostic factors after hepatectomy for hepatocellular carcinoma: a univariate and multivariate analysis. Cancer 65: 1104-1110, 1990.
22. Zhao G, Su S and Borek D: Long survival and prognostic factors in hepatocellular carcinoma. J Surg Oncol 45: 257-260, 1990.
23. Ohnishi K, Tanabe Y and Ryu M: Prognosis of hepatocellular carcinoma smaller than 5 cm in relation to treatment: study of 100 patients. Hepatology 7: 1285-1290, 1987.
24. Akashi Y, Korreda C and Enomoto S: Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 14: 262-268, 1991.
25. Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Amer Statist Assn 53: 457-481, 1958.
26. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966.
27. Cox DR: Regression models and life-tables (with discussion). J Roy Statist Soc 34: 187-220, 1972.
28. Colleoni M, Biasin MR and Boni L: Evaluation of Ki-67 expression as a prognostic feature in unresctable hepatocellular carcinoma. Eur J Cancer 31: 1147-1148, 1995.
29. Calvet X, Bruix J and Gines P: Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients. Hepatology 12: 753-760, 1990.
30. Taniguchi K, Nakata K, Kato Y and Sato Y: Treatment of hepatocellular carcinoma with transcatheter arterial embolization: analysis of prognostic factors. Cancer 73: 1341-1345, 1994.
31. Khan KN, Nakata K, Kusumoto Y and Shina M: Evaluation of non-tumorous tissue damage and trancatheter arterial embolization for HCC. Cancer Res 51: 5667-5671, 1991.
32. Takayasu K, Suzuki M, Uesaka K, Muramatsu Y and Moriyama N: Hepatic arterial embolization for inoperable hepatocellular carcinoma: prognosis and risk factors. Cancer Chemother Pharmacol 23: 123-125, 1989.
33. Ikeda K, Kumada H and Saitoh S: Effect of repeated transcatheter arterial emboliation on the survival time of patients with hepatocellular carcinoma. Cancer 68: 2150-2154, 1991.